Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 7/14/2025

Gastric Sleeve Surgery and Proton Pump Inhibitor Use

Introduction to Gastric Sleeve Surgery and GERD

  • Gastric sleeve surgery is associated with a high rate of gastroesophageal reflux disease (GERD) and reflux-related complications, with high rates of reflux and reflux-related complications reported following sleeve gastrectomy 1

PPI Use After Gastric Sleeve Surgery

  • The American College of Surgeons recommends PPI use for at least 30 days post-operatively to prevent reflux-related complications, with some centers recommending 3 months for optimal protection 1
  • Standard PPI dosing, such as omeprazole 20mg daily, lansoprazole 30mg daily, pantoprazole 40mg daily, or rabeprazole 20mg daily, may be used, and consider opening capsules to improve postoperative uptake 1

Diagnosis and Management of GERD After Gastric Sleeve Surgery

  • For patients who develop GERD symptoms after the initial post-operative period, confirm GERD diagnosis with appropriate testing, such as pH monitoring or endoscopy, and consider ambulatory 24-hour pH-impedance monitoring to determine the mechanism of persistent symptoms 2
  • Personalize adjunctive therapy based on symptom phenotype, and consider surgical options, such as laparoscopic fundoplication, magnetic sphincter augmentation, or Roux-en-Y gastric bypass, for proven GERD 2

Patient Selection for Anti-Reflux Procedures

  • Patient selection for anti-reflux procedures requires confirmatory evidence of pathologic GERD, assessment of esophageal peristaltic function, and exclusion of achalasia 2
  • Patients after gastric bypass require special attention to thromboprophylaxis, with both mechanical and pharmacological measures individualized, as well as nutritional care with life-long vitamin and mineral supplementation and monitoring, and proton pump inhibitor prophylaxis should be considered for at least 30 days after Roux-en-Y gastric bypass 1

Post-Operative Care and Medication Management

  • The American Society of Metabolic and Bariatric Surgery recommends no dose adjustment is needed initially for venlafaxine XR after gastric bypass surgery, based on pharmacokinetic evidence, and to monitor for therapeutic efficacy during the first 3-4 months post-surgery, while considering the patient's nutritional status 1
  • The American College of Surgeons suggests watching for signs of medication side effects which could indicate altered drug metabolism, and to be vigilant for signs of serotonin syndrome if the patient is on multiple serotonergic medications 3
  • The World Health Organization notes that individual variations in absorption may occur, and patients with pre-existing severe gastrointestinal symptoms may experience more adverse events with venlafaxine XR, particularly nausea, and if a patient shows signs of therapeutic failure, consider checking drug levels or switching to immediate-release formulation with divided dosing 1